Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 89

1.

Effect of acute exercise on RBC deformability and RBC nitric oxide synthase signalling pathway in young sickle cell anaemia patients.

Grau M, Jerke M, Nader E, Schenk A, Renoux C, Collins B, Dietz T, Bizjak DA, Joly P, Bloch W, Connes P, Prokop A.

Sci Rep. 2019 Aug 14;9(1):11813. doi: 10.1038/s41598-019-48364-1.

2.

Degree of serotonin reuptake inhibition of antidepressants and ischemic risk: A cohort study.

Douros A, Dell'Aniello S, Dehghan G, Boivin JF, Renoux C.

Neurology. 2019 Aug 7. pii: 10.1212/WNL.0000000000008060. doi: 10.1212/WNL.0000000000008060. [Epub ahead of print]

PMID:
31391245
3.

The Reply.

Renoux C, Azoulay L, Dell'Aniello S, Yu OHY.

Am J Med. 2019 Jul 26. pii: S0002-9343(19)30545-5. doi: 10.1016/j.amjmed.2019.06.010. [Epub ahead of print] No abstract available.

PMID:
31352973
4.

Combined and differential effects of alpha-thalassemia and HbF-quantitative trait loci in Senegalese hydroxyurea-free children with sickle cell anemia.

Gueye Tall F, Martin C, Ndour EHM, Renoux C, Ly ID, Connes P, Gueye PM, Diallo RN, Diagne I, Diop PA, Cissé A, Lopez Sall P, Joly P.

Pediatr Blood Cancer. 2019 Jul 19:e27934. doi: 10.1002/pbc.27934. [Epub ahead of print]

PMID:
31322815
5.

Differential effects of adenylyl cyclase-protein kinase A cascade on shear-induced changes of sickle cell deformability.

Ugurel E, Connes P, Yavas G, Eglenen B, Turkay M, Aksu AC, Renoux C, Joly P, Gauthier A, Hot A, Bertrand Y, Cannas G, Yalcin O.

Clin Hemorheol Microcirc. 2019 Jul 8. doi: 10.3233/CH-190563. [Epub ahead of print]

PMID:
31306111
6.

Testosterone Replacement Therapy and the Risk of Prostate Cancer in Men with Late-Onset Hypogonadism.

Santella C, Renoux C, Yin H, Yu OHY, Azoulay L.

Am J Epidemiol. 2019 May 30. pii: kwz138. doi: 10.1093/aje/kwz138. [Epub ahead of print]

PMID:
31145457
7.

Impact of surface-area-to-volume ratio, internal viscosity and membrane viscoelasticity on red blood cell deformability measured in isotonic condition.

Renoux C, Faivre M, Bessaa A, Da Costa L, Joly P, Gauthier A, Connes P.

Sci Rep. 2019 May 1;9(1):6771. doi: 10.1038/s41598-019-43200-y.

8.

Cardiovascular and Cerebrovascular Safety of Testosterone Replacement Therapy Among Aging Men with Low Testosterone Levels: A Cohort Study.

Loo SY, Azoulay L, Nie R, Dell'Aniello S, Yu OHY, Renoux C.

Am J Med. 2019 Apr 3. pii: S0002-9343(19)30281-5. doi: 10.1016/j.amjmed.2019.03.022. [Epub ahead of print]

PMID:
30953635
9.

Red blood cells modulate structure and dynamics of venous clot formation in sickle cell disease.

Faes C, Ilich A, Sotiaux A, Sparkenbaugh EM, Henderson MW, Buczek L, Beckman JD, Ellsworth P, Noubouossie DF, Bhoopat L, Piegore M, Renoux C, Bergmeier W, Park Y, Ataga KI, Cooley B, Wolberg AS, Key NS, Pawlinski R.

Blood. 2019 Jun 6;133(23):2529-2541. doi: 10.1182/blood.2019000424. Epub 2019 Apr 5.

PMID:
30952675
10.

Abatacept initiation in rheumatoid arthritis and the risk of serious infection: A population-based cohort study.

Montastruc F, Renoux C, Hudson M, Dell'Aniello S, Simon TA, Suissa S.

Semin Arthritis Rheum. 2019 Jun;48(6):1053-1058. doi: 10.1016/j.semarthrit.2019.01.009. Epub 2019 Jan 25.

PMID:
30772001
11.

Evaluation of agreement between hemoglobin A1c, fasting glucose, and fructosamine in Senegalese individuals with and without sickle-cell trait.

Skinner S, Diaw M, Ndour Mbaye M, Joly P, Renoux C, Masson C, Cuerq C, Lopez P, Ndour M, Diedhiou D, Sow D, Diop S, Samb A, Pialoux V, Connes P.

PLoS One. 2019 Feb 15;14(2):e0212552. doi: 10.1371/journal.pone.0212552. eCollection 2019.

12.

Automatic depletion with Spectra Optia allows a safe 16% reduction of red blood cell pack consumption in exchanged sickle cell anemia patients.

Hequet O, Poutrel S, Connes P, Revesz D, Chelghoum Y, Kebaili K, Cannas G, Gauthier A, Guironnet-Paquet A, Vocanson M, Nicolas JF, Renoux C, Raba M, Cognasse F, Bertrand Y, Hot A, Joly P.

Transfusion. 2019 May;59(5):1692-1697. doi: 10.1111/trf.15188. Epub 2019 Feb 12.

PMID:
30747440
13.

Association of Aripiprazole With the Risk for Psychiatric Hospitalization, Self-harm, or Suicide.

Montastruc F, Nie R, Loo S, Rej S, Dell'Aniello S, Micallef J, Suissa S, Renoux C.

JAMA Psychiatry. 2019 Apr 1;76(4):409-417. doi: 10.1001/jamapsychiatry.2018.4149.

PMID:
30698607
14.

Concomitant Use of Direct Oral Anticoagulants with Antiplatelet Agents and the Risk of Major Bleeding in Patients with Nonvalvular Atrial Fibrillation.

Douros A, Renoux C, Yin H, Filion KB, Suissa S, Azoulay L.

Am J Med. 2019 Feb;132(2):191-199.e12. doi: 10.1016/j.amjmed.2018.10.008. Epub 2018 Oct 25.

PMID:
30691551
15.

Erratum. Increased Prevalence of Type 2 Diabetes-Related Complications in Combined Type 2 Diabetes and Sickle Cell Trait. Diabetes Care 2018;41:2595-2602.

Skinner SC, Diaw M, Pialoux V, Mbaye MN, Mury P, Lopez P, Bousquet D, Gueye F, Diedhiou D, Joly P, Renoux C, Sow D, Diop S, Ranque B, Vinet A, Samb A, Guillot N, Connes P.

Diabetes Care. 2019 Mar;42(3):494. doi: 10.2337/dc19-er03b. Epub 2019 Jan 23. No abstract available.

16.

Drepa-Opia: A Pilot Study to Determine the Predictive Factors of Morphine Use and Consumption in Hospitalized Adult Patients with Sickle Cell Disease.

Sabrie M, Cannas G, Tazarourte K, Poutrel S, Connes P, Hot A, Renoux C, Fattoum J, Joly P.

Hemoglobin. 2018 Jul;42(4):217-224. doi: 10.1080/03630269.2018.1529602. Epub 2019 Jan 3.

PMID:
30604640
17.

Abatacept initiation in rheumatoid arthritis and the risk of cancer: a population-based comparative cohort study.

Montastruc F, Renoux C, Dell'Aniello S, Simon TA, Azoulay L, Hudson M, Suissa S.

Rheumatology (Oxford). 2019 Apr 1;58(4):683-691. doi: 10.1093/rheumatology/key352.

PMID:
30535094
18.

Trends in First Gabapentin and Pregabalin Prescriptions in Primary Care in the United Kingdom, 1993-2017.

Montastruc F, Loo SY, Renoux C.

JAMA. 2018 Nov 27;320(20):2149-2151. doi: 10.1001/jama.2018.12358. No abstract available. Erratum in: JAMA. 2019 Feb 19;321(7):709. JAMA. 2019 Apr 23;321(16):1636.

19.

Hydroxyurea therapy modulates sickle cell anemia red blood cell physiology: Impact on RBC deformability, oxidative stress, nitrite levels and nitric oxide synthase signalling pathway.

Nader E, Grau M, Fort R, Collins B, Cannas G, Gauthier A, Walpurgis K, Martin C, Bloch W, Poutrel S, Hot A, Renoux C, Thevis M, Joly P, Romana M, Guillot N, Connes P.

Nitric Oxide. 2018 Dec 1;81:28-35. doi: 10.1016/j.niox.2018.10.003. Epub 2018 Oct 19.

PMID:
30342855
20.

Increased Prevalence of Type 2 Diabetes-Related Complications in Combined Type 2 Diabetes and Sickle Cell Trait.

Skinner SC, Diaw M, Pialoux V, Mbaye MN, Mury P, Lopez P, Bousquet D, Gueye F, Diedhiou D, Joly P, Renoux C, Sow D, Diop S, Ranque B, Vinet A, Samb A, Guillot N, Connes P.

Diabetes Care. 2018 Dec;41(12):2595-2602. doi: 10.2337/dc18-1289. Epub 2018 Oct 16. Erratum in: Diabetes Care. 2019 Mar;42(3):494.

PMID:
30327363
21.

Description of 22 new alpha-1 antitrypsin genetic variants.

Renoux C, Odou MF, Tosato G, Teoli J, Abbou N, Lombard C, Zerimech F, Porchet N, Chapuis Cellier C, Balduyck M, Joly P.

Orphanet J Rare Dis. 2018 Sep 17;13(1):161. doi: 10.1186/s13023-018-0897-0.

22.

Tamoxifen administration and the risk of Parkinsonism.

Montastruc F, Khosrow-Khavar F, Sommet A, Renoux C, Montastruc JL.

Eur J Clin Pharmacol. 2019 Jan;75(1):135-136. doi: 10.1007/s00228-018-2554-x. Epub 2018 Sep 10. No abstract available.

PMID:
30203127
23.

Use of Dipeptidyl Peptidase-4 Inhibitors and New-onset Rheumatoid Arthritis in Patients with Type 2 Diabetes.

Douros A, Abrahami D, Yin H, Yu OHY, Renoux C, Hudson M, Azoulay L.

Epidemiology. 2018 Nov;29(6):904-912. doi: 10.1097/EDE.0000000000000891.

PMID:
30028343
24.

Tamoxifen and the risk of Parkinsonism: a case/non-case study.

Montastruc F, Khosrow-Khavar F, de Germay S, Renoux C, Rousseau V, Durrieu G, Montastruc M, Rascol O, Sommet A, Lapeyre-Mestre M, Benevent J, Montastruc JL.

Eur J Clin Pharmacol. 2018 Sep;74(9):1181-1184. doi: 10.1007/s00228-018-2496-3. Epub 2018 Jun 3.

PMID:
29862427
25.

Blood rheology in children with the S/β+-thalassemia syndrome.

Renoux C, Joly P, Gauthier A, Pialoux V, Romanet-Faes C, Bertrand Y, Garnier N, Cuzzubbo D, Cannas G, Connes P.

Clin Hemorheol Microcirc. 2018;69(1-2):207-214. doi: 10.3233/CH-189119.

PMID:
29630544
26.

Blood rheological abnormalities in sickle cell anemia.

Connes P, Renoux C, Romana M, Abkarian M, Joly P, Martin C, Hardy-Dessources MD, Ballas SK.

Clin Hemorheol Microcirc. 2018;68(2-3):165-172. doi: 10.3233/CH-189005.

PMID:
29614630
27.

Trends in initiation of direct oral anticoagulant therapies for atrial fibrillation in a national population-based cross-sectional study in the French health insurance databases.

Huiart L, Ferdynus C, Renoux C, Beaugrand A, Lafarge S, Bruneau L, Suissa S, Maillard O, Ranouil X.

BMJ Open. 2018 Mar 30;8(3):e018180. doi: 10.1136/bmjopen-2017-018180.

28.

Dipeptidyl peptidase-4 inhibitors and incidence of inflammatory bowel disease among patients with type 2 diabetes: population based cohort study.

Abrahami D, Douros A, Yin H, Yu OHY, Renoux C, Bitton A, Azoulay L.

BMJ. 2018 Mar 21;360:k872. doi: 10.1136/bmj.k872.

29.

Risk of Intracranial Hemorrhage Associated with the Use of Antidepressants Inhibiting Serotonin Reuptake: A Systematic Review.

Douros A, Ades M, Renoux C.

CNS Drugs. 2018 Apr;32(4):321-334. doi: 10.1007/s40263-018-0507-7.

PMID:
29536379
30.

Non-Vitamin K Antagonist Oral Anticoagulants and Risk of Serious Liver Injury.

Douros A, Azoulay L, Yin H, Suissa S, Renoux C.

J Am Coll Cardiol. 2018 Mar 13;71(10):1105-1113. doi: 10.1016/j.jacc.2018.01.009.

31.

Association between Oxidative Stress, Genetic Factors, and Clinical Severity in Children with Sickle Cell Anemia.

Renoux C, Joly P, Faes C, Mury P, Eglenen B, Turkay M, Yavas G, Yalcin O, Bertrand Y, Garnier N, Cuzzubbo D, Gauthier A, Romana M, Möckesch B, Cannas G, Antoine-Jonville S, Pialoux V, Connes P.

J Pediatr. 2018 Apr;195:228-235. doi: 10.1016/j.jpeds.2017.12.021. Epub 2018 Feb 13.

PMID:
29449005
32.

Comparative effectiveness of novel oral anticoagulants in UK patients with non-valvular atrial fibrillation and chronic kidney disease: a matched cohort study.

Loo SY, Coulombe J, Dell'Aniello S, Brophy JM, Suissa S, Renoux C.

BMJ Open. 2018 Jan 24;8(1):e019638. doi: 10.1136/bmjopen-2017-019638.

33.

Eryptosis and hemorheological responses to maximal exercise in athletes: Comparison between running and cycling.

Nader E, Guillot N, Lavorel L, Hancco I, Fort R, Stauffer E, Renoux C, Joly P, Germain M, Connes P.

Scand J Med Sci Sports. 2018 May;28(5):1532-1540. doi: 10.1111/sms.13059. Epub 2018 Feb 14.

PMID:
29356101
34.

Higher Daily Physical Activity Level Is Associated with Lower RBC Aggregation in Carotid Artery Disease Patients at High Risk of Stroke.

Mury P, Faes C, Millon A, Mura M, Renoux C, Skinner S, Nicaise V, Joly P, Della Schiava N, Lermusiaux P, Connes P, Pialoux V.

Front Physiol. 2017 Dec 12;8:1043. doi: 10.3389/fphys.2017.01043. eCollection 2017.

35.

Comparative effect of statins on the risk of incident Alzheimer disease.

Sinyavskaya L, Gauthier S, Renoux C, Dell'Aniello S, Suissa S, Brassard P.

Neurology. 2018 Jan 16;90(3):e179-e187. doi: 10.1212/WNL.0000000000004818. Epub 2017 Dec 15.

PMID:
29247073
36.

Testosterone replacement therapy and the risk of stroke in men: A systematic review.

Loo SY, Chen BY, Yu OHY, Azoulay L, Renoux C.

Maturitas. 2017 Dec;106:31-37. doi: 10.1016/j.maturitas.2017.08.013. Epub 2017 Sep 1. Review.

PMID:
29150164
37.

Comparative safety of direct oral anticoagulants and warfarin in venous thromboembolism: multicentre, population based, observational study.

Jun M, Lix LM, Durand M, Dahl M, Paterson JM, Dormuth CR, Ernst P, Yao S, Renoux C, Tamim H, Wu C, Mahmud SM, Hemmelgarn BR; Canadian Network for Observational Drug Effect Studies (CNODES) Investigators.

BMJ. 2017 Oct 17;359:j4323. doi: 10.1136/bmj.j4323.

38.

Patterns of long-term use of non-vitamin K antagonist oral anticoagulants for non-valvular atrial fibrillation: Quebec observational study.

Douros A, Renoux C, Coulombe J, Suissa S.

Pharmacoepidemiol Drug Saf. 2017 Dec;26(12):1546-1554. doi: 10.1002/pds.4333. Epub 2017 Oct 6.

PMID:
28984052
39.

Letter by Ganesh and Renoux Regarding Article, "Sex Differences and Functional Outcome After Intravenous Thrombolysis".

Ganesh A, Renoux C.

Stroke. 2017 Nov;48(11):e329. doi: 10.1161/STROKEAHA.117.018883. Epub 2017 Sep 22. No abstract available.

PMID:
28939671
40.

SERPINA1 and MAN1B1 polymorphisms are not linked to severe liver disease in a French cohort of alpha-1 antitrypsin deficiency children.

Joly P, Lachaux A, Ruiz M, Restier L, Belmalih A, Chapuis-Cellier C, Francina A, Renoux C, Bouchecareilh M.

Liver Int. 2017 Nov;37(11):1608-1611. doi: 10.1111/liv.13586. Epub 2017 Sep 15.

PMID:
28887821
41.

Confounding by Pre-Morbid Functional Status in Studies of Apparent Sex Differences in Severity and Outcome of Stroke.

Renoux C, Coulombe J, Li L, Ganesh A, Silver L, Rothwell PM; Oxford Vascular Study.

Stroke. 2017 Oct;48(10):2731-2738. doi: 10.1161/STROKEAHA.117.018187. Epub 2017 Aug 10.

42.

Plasmapheresis may improve clinical condition in sickle cell disease through its effects on red blood cell rheology.

Nader E, Connes P, Lamarre Y, Renoux C, Joly P, Hardy-Dessources MD, Cannas G, Lemonne N, Ballas SK.

Am J Hematol. 2017 Nov;92(11):E629-E630. doi: 10.1002/ajh.24870. Epub 2017 Aug 17. No abstract available.

43.

Genetic Background of the Sickle Cell Disease Pediatric Population of Dakar, Senegal, and Characterization of a Novel Frameshift β-Thalassemia Mutation [HBB: c.265_266del; p.Leu89Glufs*2].

Gueye Tall F, Martin C, Malick Ndour EH, Déme Ly I, Renoux C, Chillotti L, Veyrenche N, Connes P, Madieye Gueye P, Ndiaye Diallo R, Lacan P, Diagne I, Amadou Diop P, Cissé A, Lopez Sall P, Joly P.

Hemoglobin. 2017 Mar;41(2):89-95. doi: 10.1080/03630269.2017.1339610. Epub 2017 Jul 3.

PMID:
28670947
44.

Inappropriate Comparator Group in Study of Selective Serotonin Reuptake Inhibitors and Risk for Intracranial Hemorrhage-Reply.

Renoux C, Dell'Aniello S, Boivin JF.

JAMA Neurol. 2017 Jul 1;74(7):870-871. doi: 10.1001/jamaneurol.2017.0541. No abstract available.

PMID:
28492857
45.

Trends in the prescription of novel oral anticoagulants in UK primary care.

Loo SY, Dell'Aniello S, Huiart L, Renoux C.

Br J Clin Pharmacol. 2017 Sep;83(9):2096-2106. doi: 10.1111/bcp.13299. Epub 2017 May 4.

46.

Bias from depletion of susceptibles: the example of hormone replacement therapy and the risk of venous thromboembolism.

Renoux C, Dell'Aniello S, Brenner B, Suissa S.

Pharmacoepidemiol Drug Saf. 2017 May;26(5):554-560. doi: 10.1002/pds.4197. Epub 2017 Mar 22.

PMID:
28326633
47.

Alpha-thalassaemia promotes frequent vaso-occlusive crises in children with sickle cell anaemia through haemorheological changes.

Renoux C, Connes P, Nader E, Skinner S, Faes C, Petras M, Bertrand Y, Garnier N, Cuzzubbo D, Divialle-Doumdo L, Kebaïli K, Renard C, Gauthier A, Etienne-Julan M, Cannas G, Martin C, Hardy-Dessources MD, Pialoux V, Romana M, Joly P.

Pediatr Blood Cancer. 2017 Aug;64(8). doi: 10.1002/pbc.26455. Epub 2017 Jan 18.

PMID:
28097791
48.

Revisiting sex differences in outcomes in non-valvular atrial fibrillation: a population-based cohort study.

Renoux C, Coulombe J, Suissa S.

Eur Heart J. 2017 May 14;38(19):1473-1479. doi: 10.1093/eurheartj/ehw613.

PMID:
28073863
49.

UGT1A1 (TA)n genotype is not the major risk factor of cholelithiasis in sickle cell disease children.

Joly P, Renoux C, Lacan P, Bertrand Y, Cannas G, Garnier N, Cuzzubbo D, Kebaïli K, Renard C, Gauthier A, Pialoux V, Martin C, Romana M, Connes P.

Eur J Haematol. 2017 Mar;98(3):296-301. doi: 10.1111/ejh.12838. Epub 2017 Jan 9.

PMID:
27981643
50.

Association of Selective Serotonin Reuptake Inhibitors With the Risk for Spontaneous Intracranial Hemorrhage.

Renoux C, Vahey S, Dell'Aniello S, Boivin JF.

JAMA Neurol. 2017 Feb 1;74(2):173-180. doi: 10.1001/jamaneurol.2016.4529.

PMID:
27918771

Supplemental Content

Loading ...
Support Center